Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (4): 550-555.doi: 10.19982/j.issn.1000-6621.20250473
• Review Articles • Previous Articles Next Articles
Qiu Yuxian, Huang Fang(
), Yang Xiaoyi, Yang Feng, Lu Hua, Zhang Tianyi, Zhang Yang, Yao Rong, Li Yuanyuan
Received:2025-12-02
Online:2026-04-10
Published:2026-04-02
Contact:
Huang Fang,Email:736545650@qq.com
Supported by:CLC Number:
Qiu Yuxian, Huang Fang, Yang Xiaoyi, Yang Feng, Lu Hua, Zhang Tianyi, Zhang Yang, Yao Rong, Li Yuanyuan. Research progress in digital twin technology for tuberculosis patient management[J]. Chinese Journal of Antituberculosis, 2026, 48(4): 550-555. doi: 10.19982/j.issn.1000-6621.20250473
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20250473
| [1] | 屈燕, 李涛, 马文斌, 等. 世界卫生组织《2025年全球结核病报告》解读. 结核与肺部疾病杂志, 2025, 6(6): 613-623. doi:10.19983/j.issn.2096-8493.20250178. |
| [2] | Mudzengi DL, Chomutare H, Nagudi J, et al. Using mHealth Technologies for Case Finding in Tuberculosis and Other Infectious Diseases in Africa: Systematic Review. JMIR MHealth UHealth, 2024, 12: e53211. doi:10.2196/53211. |
| [3] | 李智, 周惠, 陈晓军, 等. 基于数字技术的结核病患者管理方法研究进展. 中国防痨杂志, 2019, 41(9): 1015-1020. doi:10.3969/j.issn.1000-6621.2019.09.019. |
| [4] | 李成坤, 王锦华, 刘志东, 等. 基于数字技术结核病防控管理的卫生经济学评价. 新发传染病电子杂志, 2025, 10(2): 63-69. doi:10.19871/j.cnki.xfcrbzz.2025.02.011. |
| [5] |
Indawati E, Kosasih CE, Haroen H, et al. Technology-integrated nursing interventions to improve adherence to tuberculosis medication: a scoping review. BMC Nurs, 2025, 24(1):1160. doi:10.1186/s12912-025-03796-1.
pmid: 40898157 |
| [6] | Dihan MS, Akash AI, Tasneem Z, et al. Digital twin: Data exploration, architecture, implementation and future. Heliyon, 2024, 10(5): e26503. doi:10.1016/j.heliyon.2024.e26503. |
| [7] | Netto JT, Maia MR, Silva MLBD, et al. The role of digital health technology in tuberculosis control: a systematic literature review and comparative analysis based on the WHO guidelines. Discov Health Syst, 2025, 4:66. doi:10.1007/s44250-025-00242-6. |
| [8] | 李哲青, 陈一贤, 周邮, 等. 数字孪生技术及其在医疗领域的应用. 中国数字医学, 2023, 18(8): 56-61. doi:10.3969/j.issn.1673-7571.2023.08.010. |
| [9] | 陈岳飞, 王思思, 田明棋, 等. 数字孪生技术在医疗健康领域的应用及研究进展. 计量科学与技术, 2021, 65(10): 6-9. doi:10.12338/j.issn.2096-9015.2021.0050. |
| [10] | Zhang K, Zhou HY, Baptista-Hon DT, et al. Concepts and applications of digital twins in healthcare and medicine. Patterns (N Y), 2024, 5(8): 101028. doi:10.1016/j.patter.2024.101028. |
| [11] | 何晓菲, 朱蓝玉, 李佳, 等. 数字孪生在慢性病精准护理中的研究进展. 护理学杂志, 2024, 39(24):120-123. doi:10.3870/j.issn.1001-4152.2024.24.120. |
| [12] | Nagaraj D, Khandelwal P, Steyaert S, et al. Augmenting digital twins with federated learning in medicine. Lancet Digit Health, 2023, 5(5): e251-e253. doi:10.1016/S2589-7500(23)00044-4. |
| [13] | Iqbal JD, Krauthammer M, Biller-Andorno N. The Use and Ethics of Digital Twins in Medicine. J Law Med Ethics, 2022, 50(3): 583-596. doi:10.1017/jme.2022.97. |
| [14] | Abdulmalek S, Nasir A, Jabbar WA, et al. IoT-Based Healthcare-Monitoring System towards Improving Quality of Life: A Review. Healthcare (Basel), 2022, 10(10): 1993. doi:10.3390/healthcare10101993. |
| [15] | Viceconti M, De Vos M, Mellone S, et al. Position paper From the digital twins in healthcare to the Virtual Human Twin: a moon-shot project for digital health research. IEEE J Biomed Health Inform, 2023, 27(12): 5678-5686. doi:10.1109/JBHI.2023.3323688. |
| [16] | 林雨嘉, 李金海, 宁焕生, 等. 数字孪生技术在智慧医疗与健康领域的技术、应用与挑战综述. 工程科学学报, 2025, 47(9): 1812-1824. doi:10.13374/j.issn2095-9389.2024.12.30.002. |
| [17] | 王桢絮, 张波, 顾莺, 等. 数字孪生技术在医疗领域的应用进展. 中国医疗器械信息, 2023, 29(9): 77-81. doi:10.3969/j.issn.1006-6586.2023.09.021. |
| [18] | Armeni P, Polat I, De Rossi LM, et al. Digital Twins in Healthcare: Is It the Beginning of a New Era of Evidence-Based Medicine? A Critical Review. J Pers Med, 2022, 12(8): 1255. doi:10.3390/jpm12081255. |
| [19] | 陶飞, 刘儒然, 刘检华, 等. 数字孪生及其应用探索. 计算机集成制造系统, 2018, 24(1): 1-18. doi:10.13196/j.cims.2018.01.001. |
| [20] | Emmert-Streib F, Yli-Harja O. What Is a Digital Twin? Experimental Design for a Data-Centric Machine Learning Perspective in Health. Int J Mol Sci, 2022, 23(21): 13149. doi:10.3390/ijms232113149. |
| [21] |
Katsoulakis E, Wang Q, Wu H, et al. Digital twins for health: a scoping review. NPJ Digit Med, 2024, 7(1):77. doi:10.1038/s41746-024-01073-0.
pmid: 38519626 |
| [22] | Carbonaro A, Marfoglia A, Quaranta L, et al. Editorial: Implementing digital twins in healthcare: pathways to person-centric solutions. Front Digit Health, 2025, 7:1741466. doi:10.3389/fdgth.2025.1741466. |
| [23] | Varsha DC, MB Anandaraju, Manojkumar SB, et al. AI-Powered VLSI-Enabled Smart Pillbox for Real-Time Medication Adherence Monitoring and Automated Dispensing. 2025 International Conference on Recent Advances in Electrical, Electronics, Ubiquitous Communication, and Computational Intelligence (RAEEUCCI), Chennai, India, 2025:1-6. doi:10.1109/RAEEUCCI63961.2025.11048297. |
| [24] | Sadée C, Testa S, Barba T, et al. Medical digital twins: enabling precision medicine and medical artificial intelligence. Lancet Digit Health, 2025, 7(7): 100864. doi:10.1016/j.landig.2025.02.004. |
| [25] | Park S, Moon N, Oh B, et al. Improving Treatment Adherence with Integrated Patient Management for TB Patients in Morocco. Int J Environ Res Public Health, 2021, 18(19): 9991. doi:10.3390/ijerph18199991. |
| [26] |
Byonanebye DM, Mackline H, Sekaggya-Wiltshire C, et al. Impact of a mobile phone-based interactive voice response software on tuberculosis treatment outcomes in Uganda (CFL-TB): a protocol for a randomized controlled trial. Trials, 2021, 22(1):391. doi:10.1186/s13063-021-05352-z.
pmid: 34120649 |
| [27] | 张晗, 王丽霞, 魏玉石, 等. 数字化治疗依从性技术在肺结核患者服药管理中的应用效果评价. 中国防痨杂志, 2024, 46(2): 158-164. doi:10.19982/j.issn.1000-6621.20230283. |
| [28] | Johnson Z, Saikia MJ. Digital Twins for Healthcare Using Wearables. Bioengineering (Basel), 2024, 11(6): 606. doi:10.3390/bioengineering11060606. |
| [29] | Kumar S, Sharma S, Megra KT. Transformer enabled multi-modal medical diagnosis for tuberculosis classification. J Big Data, 2025, 12(1): article number 5. doi:10.1186/s40537-024-01054-w. |
| [30] | 肖敬达, 黄玉麟, 刘博闻, 等. 基于特征选择下机器学习的活动性结核病辅助诊断. 厦门大学学报(自然科学版), 2024, 63(1): 134-141. doi:10.6043/j.issn.0438-0479.202306017. |
| [31] | Sharma H, Kaur S. Patient-Specific Digital Twins for Persona-lized Healthcare: A Hybrid AI and Simulation-Based Framework. IEEE Access, 2025, 13: 143277-143290. doi:10.1109/ACCESS.2025.3598130. |
| [32] | Theobald SJ, Dahm K, Lange D, et al. Deep immune profiling delineates hallmarks of disease heterogeneity in extrapulmonary tuberculosis. Nat Commun, 2025, 16(1): 9662. doi:10.1038/s41467-025-65561-x. |
| [33] | Adibi S, Rajabifard A, Shojaei D, et al. Enhancing Healthcare through Sensor-Enabled Digital Twins in Smart Environments: A Comprehensive Analysis. Sensors (Basel), 2024, 24(9):2793. doi:10.3390/s24092793. |
| [34] | Maipan-Uku JY, Cavus N. Forecasting tuberculosis incidence: a review of time series and machine learning models for prediction and eradication strategies. Int J Environ Health Res, 2025, 35(3):645-660. doi:10.1080/09603123.2024.2368137. |
| [35] | 吴璇, 张艳秋, 孙定勇. 机器学习在结核病监测预警及干预策略效果评价上的应用. 中华流行病学杂志, 2025, 46(8):1495-1501. doi:10.3760/cma.j.cn112338-20241209-00782. |
| [36] | Lai NH, Shen WC, Lee CN, et al. Comparison of the predictive outcomes for anti-tuberculosis drug-induced hepatotoxicity by different machine learning techniques. Comput Methods Programs Biomed, 2020, 188:105307. doi:10.1016/j.cmpb.2019.105307. |
| [37] |
Robison HM, Chapman CA, Zhou H, et al. Risk assessment of latent tuberculosis infection through a multiplexed cytokine biosensor assay and machine learning feature selection. Sci Rep, 2021, 11(1):20544. doi:10.1038/s41598-021-99754-3.
pmid: 34654869 |
| [38] |
Chen JF, Jiang YL, Li ZH, et al. Predictive machine learning models for anticipating loss to follow-up in tuberculosis patients throughout anti-TB treatment journey. Sci Rep, 2024, 14(1):24685. doi:10.1038/s41598-024-74942-z.
pmid: 39433802 |
| [39] | Wang C, Li G, Ruan H, et al. A predictive model for evaluating the risk of latent tuberculosis relapse via machine learning. BMC Infect Dis, 2025, 25(1): 1470. doi:10.1186/s12879-025-11881-8. |
| [40] |
Juárez MA, Pennisi M, Russo G, et al. Generation of digital patients for the simulation of tuberculosis with UISS-TB. BMC Bioinformatics, 2020, 21(Suppl 17): 449. doi:10.1186/s12859-020-03776-z.
pmid: 33308156 |
| [41] | Russo G, Sgroi G, Parasiliti Palumbo GA, et al. Moving forward through the in silico modeling of tuberculosis: a further step with UISS-TB. BMC Bioinformatics, 2020, 21(Suppl17): 458. doi:10.1186/s12859-020-03762-5. |
| [42] | Joslyn LR, Linderman JJ, Kirschner DE. A virtual host model of Mycobacterium tuberculosis infection identifies early immune events as predictive of infection outcomes. J Theor Biol, 2022, 539: 111042. doi:10.1016/j.jtbi.2022.111042. |
| [43] | 张在房, 孙金, 高楠, 等. 基于数字孪生的肺结节诊断. 计算机集成制造系统, 2023, 29(6):1894-1904. doi:10.13196/j.cims.2023.06.009. |
| [44] | Laubenbacher R, Adler F, An G, et al. Toward mechanistic medical digital twins: some use cases in immunology. Front Digit Health, 2024, 6: 1349595. doi:10.3389/fdgth.2024.1349595. |
| [45] | 顾耀文, 郑思, 杨丰春, 等. 基于图神经网络的抗结核杆菌药物虚拟筛选模型的建立及应用. 数据分析与知识发现, 2022, 6(11): 93-102. doi:10.11925/infotech.2096-3467.2022.0196. |
| [46] | An G, Cockrell C. Drug Development Digital Twins for Drug Discovery, Testing and Repurposing: A Schema for Requirements and Development. Front Syst Biol, 2022, 2:928387. doi:10.3389/fsysb.2022.928387. |
| [47] | Canales CSC, Pavan AR, Dos Santos JL, et al. In silico drug design strategies for discovering novel tuberculosis therapeutics. Expert Opin Drug Discov, 2024, 19(4):471-491. doi:10.1080/17460441.2024.2319042. |
| [48] | Deng M, Li F, Tang F, et al. Digital twin-based bronchoscopy simulator improves training performance and skill retention of novices: a randomised controlled study. Thorax, 2025: thorax-2025-223147. doi:10.1136/thorax-2025-223147. |
| [49] |
Barat S, Parchure R, Darak S, et al. An Agent-Based Digital Twin for Exploring Localized Non-pharmaceutical Interventions to Control COVID-19 Pandemic. Trans Indian Natl Acad Eng, 2021, 6(2):323-353. doi:10.1007/s41403-020-00197-5.
pmid: 35837574 |
| [50] | Cheng W, Lian W, Tian J. Building the hospital intelligent twins for all-scenario intelligence health care. Digit Health, 2022, 8:20552076221107894. doi:10.1177/20552076221107894. |
| [51] | Hao J, Liang YX, Zhao HQ, et al. Forecasting Global Tuberculosis Incidence Rates Using a Multi-Variate Input, Multi-Region, Multi-Step Output Integrated Model: SP-CTLA. Trans GIS, 2025, 29(3):e70060. doi:10.1111/tgis.70060. |
| [52] | Zhang F, Yang Z, Geng X, et al. Using Machine Learning Methods to Predict Early Treatment Outcomes for Multidrug-Resistant or Rifampicin-Resistant Tuberculosis to Enhance Patient Cure Rates: Development and Validation of Multiple Models. J Med Internet Res, 2025, 27: e69998. doi:10.2196/69998. |
| [1] | . Guidelines for the diagnosis and treatment of superficial lymph node tuberculosis with integrated traditional Chinese and Western medicine [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 429-447. |
| [2] | Ji Lianrong, Xue Yunlian, Jiang Xue, Yuan Shasha, Liu Guihao, Wang Xiaowan, Zou Xia, Wang Tingting, Zhou Zhanqi, Zhou Lin. Spatio-temporal distribution and clustering characteristics of comorbidities among tuberculosis inpatients in Guangdong Province from 2016 to 2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 448-458. |
| [3] | Liu Xi, Liu Yuze, Hua Weiyu, Li Jie, Zhang Ying, Dong Bin. Epidemiological characteristics of pulmonary tuberculosis among residents in Haidian District,Beijing from 2012 to 2022 and its correlation with population density [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 459-467. |
| [4] | Wang Yongbing, Zhong Yuexiang, Fu Xiuying, Zhang Ying, Weng Wenpei, Zhou Fangjing, Yang Yingzhou, Luo Jilun. Survey of Mycobacterium tuberculosis infection rate and analysis of associated factors among three priority populations in Yingde’s zero-TB community pilot areas,Guangdong Province [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 468-476. |
| [5] | Miao Honghao, Zhang Jie, Pang Mengdi, Ren Yixuan, Deng Yang, Yi Junli, Fan Ruifang, Chen Shuangshuang, Chen Hao, Yu Lan, Li Jie, Li Chuanyou, Yang Xinyu. Genotypic and drug resistance of Mycobacterium tuberculosis in Beijing,2024 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 477-484. |
| [6] | Li Jing, Zhang Yangyi, Yang Jinghui, Wu Zheyuan, Li Ningdi, Yu Chenlei, Wang Lili, Shen Xuhui, Jiang Yuan, Shen Xin. Study on the characteristics of rpoB gene mutations in Mycobacterium tuberculosis and its correlation with rifampicin resistance level in Shanghai [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 485-494. |
| [7] | Zhong Guowei, Zhang Shaoyi, Fan Huiling. Expression and clinical value of serum LncRNA LINC00707 and miR-382-5p in patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 495-503. |
| [8] | Jiang Lina, Dai Wenxi, Ju Hanfang, Meng Sukai, Wang Chunhua. Clinical value of auramine O fluorescence staining automatic microscopic scanning and recognition system for detecting tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 504-509. |
| [9] | Han Yanzhuo, Lu Zhenhui, Su Ben, Zhou Rui, Chen Jiajun, Wu Xianwei, Wu Dingzhong, Zhang Shaoyan, Qiu Lei. Analysis of the clinical characteristics of post-tuberculosis bronchiectasis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 510-517. |
| [10] | Gao Xianru, Cui Wenjuan, Zhang Mengran, Yang Kefan, Hao Huiyuan, Yang Lu, Sun Wenwen. Study on the health management journey map of 15 initially treated pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 518-524. |
| [11] | Yang Jie, Dong Ning, Wei Xiaowen, Wu Yan, Dong Wenfang, Wu Yuanhao, Zhang Lin. Effects of family participatory intervention on medication adherence and lung function based on health action process approach in elderly patients with pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 525-533. |
| [12] | Du Fangfang, Cao Xuefang, Wang Jin, Jin Qi, Liu Jianjun, Gao Lei, Cheng Shiming. Analysis of current developing situation of group standards of Chinese Antituberculosis Association [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 534-540. |
| [13] | Zhou Wensi, Guo Meng, Chen Qingbo, Wang Quan, Li Wei. Comparative analysis of published literature in Chinese and English on multidrug-resistant tuberculosis from 2004 to 2025 [J]. Chinese Journal of Antituberculosis, 2026, 48(4): 541-549. |
| [14] | Shu Wei, Liu Yuhong. Interpretation of research and innovation part of the WHO Global Tuberculosis Report 2025 [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 307-312. |
| [15] | Wang Jing, Jing Wei, Li Weiwen, Zhu Qingdong, Pang Yu, Chu Naihui, Nie Wenjuan. Clinical cohort analysis of the efficacy and safety of extended-course bedaquiline in patients with multidrug-resistant/rifampicin-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2026, 48(3): 313-319. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.